FFA
IOVA icon

Farther Finance Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Farther Finance Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.7K Buy
11,508
+3,377
+42% +$10.8K ﹤0.01% 3164
2025
Q4 		$22.2K Sell
8,131
-6,491
-44% -$15K ﹤0.01% 3368
2025
Q3 		$31.7K Sell
14,622
-1,614
-10% -$3.81K ﹤0.01% 2730
2025
Q2 		$27.9K Buy
16,236
+531
+3% +$1.32K ﹤0.01% 2465
2025
Q1 		$51K Buy
15,705
+66
+0.4% +$340 ﹤0.01% 1885
2024
Q4 		$116K Buy
15,639
+250
+2% +$2.32K ﹤0.01% 1240
2024
Q3 		$145K Buy
15,389
+9,037
+142% +$85.6K 0.01% 1139
2024
Q2 		$51.2K Buy
6,352
+255
+4% +$2.73K ﹤0.01% 1405
2024
Q1 		$86.5K Buy
6,097
+6,049
+12,602% +$70.4K 0.01% 988
2023
Q4 		$390 Buy
48
+11
+30% +$58 ﹤0.01% 3057
2023
Q3 		$168 Hold
37
– – ﹤0.01% 2486
2023
Q2 		$260 Hold
37
– – ﹤0.01% 2317
2023
Q1 		$226 Buy
+37
New +$255 ﹤0.01% 2182

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return